BioTime and its wholly owned subsidiary, LifeMap Sciences, have announced an agreement to purchase XenneX. The acquisition, which is expected to close within 30 days, will merge XenneX into LifeMap Sciences. The deal is expected to ...
Tags: BioTime, XenneX, LifeMap Sciences
XenneX, a division of LifeMap Sciences, and BioTime have announced the availability of GeneCards Version 3.08. The new release includes more than 94,500 gene entries, displays about 52,000 non-protein-coding RNA genes and also shows ...
Tags: new version of clinical database, clinical industry, new product